HDAC9 and neoplasm: The xenograft experiments further confirmed that OSU-HDAC-44 induced cell apoptosis and thereby inhibited tumor growth in vivo (Fig. 5) without adversely affected body weight, major organs and hematological parameters (Fig. 6).